Skip to content

Cuff Pressure and Airway Edema in CABG With CPB

Effects of Endotracheal Tube Cuff Pressure Management on Upper Airway Edema During Cardiopulmonary Bypass in Coronary Artery Bypass Grafting: A Double-Blind, Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07148024
Enrollment
76
Registered
2025-08-29
Start date
2025-09-24
Completion date
2026-04-19
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Edema, Airway Ultrasound, Endotracheal Tube

Keywords

airway edema, coronary Bypass Greft Surgery, endotrecheal tube

Brief summary

This study investigates how endotracheal tube (ETT) cuff pressure management during cardiopulmonary bypass (CPB) in coronary artery bypass grafting (CABG) affects upper airway edema. Patients will be randomized into two groups: cuff pressure kept at 0 mmHg or maintained at 20-30 mmHg during CPB. Ultrasonography will be used to measure lateral pharyngeal wall thickness, tongue parameters, and other airway dimensions at predefined perioperative time points. The primary outcome is the change in lateral pharyngeal wall thickness as an indicator of airway edema. A total of 76 patients aged 18-80 years undergoing elective CABG with CPB will be enrolled. The results aim to clarify safe cuff pressure management strategies to reduce airway edema.

Detailed description

Purpose This study aims to evaluate the effect of endotracheal tube (ETT) cuff pressure management during cardiopulmonary bypass (CPB) in coronary artery bypass grafting (CABG) surgery on the development of upper airway edema. Ultrasonography will be used to assess changes in lateral pharyngeal wall (LPW) thickness, tongue thickness, correlation between intravenous fluid volume at multiple perioperative time points. Study Design This is a prospective, randomized, double-blind, controlled clinical trial. Patients undergoing elective CABG with CPB will be randomly assigned into two groups: Group 1: ETT cuff pressure maintained at 0 mmHg during CPB Group 2: ETT cuff pressure maintained at 20-30 mmHg during CPB Cuff pressures will be monitored with a manometer every 5 minutes and adjusted as needed. At the end of CPB, all patients will have standard cuff pressure (20-30 mmHg). Outcomes Primary outcome: Changes in LPW thickness as a marker of upper airway edema assessed by ultrasonography at five time points (T0: Preoperative T1: Before initiation of CPB T2: At the end of CPB T3: 2nd postoperative hour). Secondary outcomes: Changes in tongue thickness, correlation between intravenous fluid volume and airway edema. Participation Approximately 76 patients (18-80 years, ASA III-IV) scheduled for elective CABG with CPB will be enrolled.

Interventions

DEVICEETT cuff pressure 0 mmHg

In this group, the endotracheal tube (ETT) cuff pressure will be maintained at 0 mmHg during cardiopulmonary bypass (CPB)

DEVICEETT cuff pressure 20-30 mmHg

In this group, the endotracheal tube (ETT) cuff pressure will be maintained at 20-30 mmHg during cardiopulmonary bypass (CPB)

Sponsors

Engin Çetin
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Parallel assigment

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective coronary artery bypass grafting (CABG) surgery * Aged 18-80 years * ASA physical status class III-IV * Providing written informed consent

Exclusion criteria

* History of difficult intubation * Anatomical abnormalities of the upper airway * Body mass index (BMI) \> 35 kg/m² * Acute respiratory tract infection * Emergency surgeries

Design outcomes

Primary

MeasureTime frameDescription
Change in Lateral Pharyngeal Wall Thickness Measured by Airway UltrasoundT0: Preoperative T1: Before initiation of CPB T2: At the end of CPB T3: 2nd postoperative hourTo compare the effect of two different endotracheal tube (ETT) cuff pressures (0 mmHg vs. 20-30 mmHg) during cardiopulmonary bypass (CPB) in coronary artery bypass grafting (CABG) on upper airway edema. The degree of airway edema will be assessed by measuring changes in lateral pharyngeal wall thickness (in millimeters, mm) using ultrasound at predefined perioperative time points.

Secondary

MeasureTime frameDescription
ultrasonographic airway parameter -tongue widthT0: Preoperative T1: Before initiation of CPB T2: At the end of CPB T3: 2nd postoperative hourTo compare the effects of two different endotracheal tube (ETT) cuff pressures (0 mmHg vs. 20-30 mmHg) during cardiopulmonary bypass (CPB) in coronary artery bypass grafting (CABG) on upper airway edema. The degree of edema will be assessed by changes in ultrasonographic airway parameter, specifically tongue width (mm), measured before and after the procedure
ultrasonographic airway parameter -tongue volumeT0: Preoperative T1: Before initiation of CPB T2: At the end of CPB T3: 2nd postoperative hourTo compare the effects of two different endotracheal tube (ETT) cuff pressures (0 mmHg vs. 20-30 mmHg) during cardiopulmonary bypass (CPB) in coronary artery bypass grafting (CABG) on the development of upper airway edema, which will be assessed by ultrasonographic measurements of upper airway structures before and after the procedure, including tongue thickness (mm).Tongue thickness (millimeters, mm)
Correlation Between Intravenous Fluid Volume and Airway EdemaT0: Preoperative T1: Before initiation of CPB T2: At the end of CPB T3: 2nd postoperative hourTo evaluate the correlation between the total intravenous fluid volume administered intraoperatively and the degree of airway edema, as measured by changes in ultrasonographic airway parameters (e.g., tongue thickness, pharyngeal wall thickness) at defined time points.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATOREngin Çetin

Kocaeli City Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026